12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersJaguar Health (NASDAQ:JAGX) shares rose 25.3% to $0.11 during Tuesday's after-market session. The company's market cap stands at $31.1 million. aTyr Pharma (NASDAQ:LIFE) shares rose 10.45% to $
BenzingaApr 9 16:31 ET
ATyr Pharma to Participate in April Investor Conferences
SAN DIEGO, April 01, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its p
GlobeNewswireApr 1 08:00 ET
WW, ATNM and XTIA Are Among Pre Market Gainers
Seeking AlphaMar 19 08:04 ET
Repligen Appoints Maggie A. Pax to Board of Directors
Yahoo FinanceMar 19 07:30 ET
ATyr Pharma Full Year 2023 Earnings: Revenues Disappoint
Yahoo FinanceMar 16 08:56 ET
ATyr Pharma Is Maintained at Outperform by RBC Capital
ATyr Pharma Is Maintained at Outperform by RBC Capital
Dow JonesMar 15 12:59 ET
ATyr Pharma Inc (LIFE) Reports Full Year 2023 Financial Results and Corporate Progress
Yahoo FinanceMar 15 11:01 ET
Analysts Offer Insights on Healthcare Companies: ATyr Pharma (LIFE), Conmed (CNMD) and Ascendis Pharma (ASND)
TipRanksMar 15 06:50 ET
Buy Rating Affirmed for ATyr Pharma as Lead Candidate Efzofitimod Advances in Clinical Trials With Solid Financial Footing
TipRanksMar 15 06:25 ET
Earnings Call Summary | ATyr Pharma(LIFE.US) Q4 2023 Earnings Conference
The following is a summary of the ATyr Pharma, Inc. (LIFE) Q4 2023 Earnings Call Transcript:Financial Performance:ATyr Pharma ended 2023 with $101.7 million in cash, restricted cash, cash equivalents,
moomoo AIMar 15 01:27 ET · Conference Call
Recap: ATyr Pharma Q4 Earnings
aTyr Pharma (NASDAQ:LIFE) reported its Q4 earnings results on Thursday, March 14, 2024 at 04:00 PM.Here's what investors need to know about the announcement.EarningsaTyr Pharma missed estimated earnin
BenzingaMar 14 16:15 ET
ATyr Pharma GAAP EPS of -$0.25 Misses by $0.01
Seeking AlphaMar 14 16:04 ET
ATyr Pharma 4Q Loss/Shr 25c >LIFE
ATyr Pharma 4Q Loss/Shr 25c >LIFE
Dow JonesMar 14 16:00 ET
Notable Earnings After Thursday's Close
Seeking AlphaMar 13 17:35 ET
ATyr Pharma's Earnings Outlook
aTyr Pharma (NASDAQ:LIFE) is set to give its latest quarterly earnings report on Thursday, 2024-03-14. Here's what investors need to know before the announcement.Analysts estimate that aTyr Pharma wil
BenzingaMar 13 13:01 ET
ATyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results
Management to host conference call and webcast on March 14th at 5:00 pm EDT / 2:00 pm PDTSAN DIEGO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotechnology
GlobeNewswireFeb 28 08:00 ET
We Think ATyr Pharma (NASDAQ:LIFE) Can Afford To Drive Business Growth
Yahoo FinanceFeb 23 13:28 ET
Express News | HC Wainwright & Co. Reiterates Buy on ATyr Pharma, Maintains $35 Price Target
Moomoo 24/7Feb 21 11:16 ET
ATyr Pharma Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 02/21/2024 1704.22% HC Wainwright & Co. → $35 Reiterates Buy → Buy 09/21/2023 1704.22% HC Wainwright & Co.
BenzingaFeb 21 11:14 ET
ATyr Pharma Announces Expanded Access Program (EAP) for EFZO-FIT Clinical Trial Participants
aTyr Pharma, Inc. (NASDAQ:LIFE) (aTyr or the Company), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase
BenzingaFeb 21 08:06 ET
No Data
No Data